(E) -Belizatinib
(E) -Belizatinib ((E) -TSR-011) ) (compound 36), the (E) -isomer of Belizatinib , is a potent, selective and orally active anaplastic lymphoma kinase (ALK) Inhibitor with an enzymatic IC50 of 0.005 μM and a cellular IC50 of 0.048 μM. (E) -Belizatinib shows >61-fold selectivity over JAK2, SRC, and IGF1R. (E) -Belizatinib shows favorable potency and PK characteristics in rats and dogs. (E) -Belizatinib can be used for ALK-driven cancer research[1].
Product Specifications
CAS Number
1388225-72-6
Product Name Alternative
(E) -TSR-011
UNSPSC
12352005
Target
Anaplastic lymphoma kinase (ALK)
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C(C1=CC=C(C=C1)F)NC(N([C@H]2CC[C@H](CC2)C(NC(C)C)=O)C3=C4)=NC3=CC=C4CN5CCC(CC5)C(C)(O)C
Molecular Formula
C33H44FN5O3
Molecular Weight
577.73
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human FASN shRNA (UAS) - Lentiviral human FASN shRNA (UAS) (25)
Lentiviral human SYTL5 shRNA (UAS) - Lentiviral human SYTL5 shRNA (UAS) (100)
Bovine Anti-Mouse IgG Antibody (H&L) Antibody (biotin)